Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Long-term visual acuity between 20/20 and 20/40	2	108	Odds Ratio (M-H, Fixed, 95% CI)	1.11 [0.47, 2.61]
2 Short-term visual acuity from 20/20 to 20/40	1		Odds Ratio (M-H, Fixed, 95% CI)	Totals not selected
3 Final visual acuity between 20/20 and 20/40	2	143	Odds Ratio (M-H, Fixed, 95% CI)	1.56 [0.53, 4.56]
4 Time to resolution of primary hemorrhage (days)			Other data	No numeric data
5 Risk of secondary hemorrhage	6	330	Odds Ratio (M-H, Fixed, 95% CI)	0.25 [0.11, 0.57]
6 Time to rebleed (days)			Other data	No numeric data
7 Risk of corneal blood stain	1		Odds Ratio (M-H, Fixed, 95% CI)	Totals not selected
8 Risk of glaucoma or elevated intraocular pressure (IOP)	2	83	Odds Ratio (M-H, Fixed, 95% CI)	0.35 [0.06, 1.98]
9 Risk of glaucoma or increases in IOP			Other data	No numeric data
9.1 Transient increase in IOP			Other data	No numeric data
9.2 Persistent increase in IOP			Other data	No numeric data
10 Risk of optic atrophy	1		Odds Ratio (M-H, Fixed, 95% CI)	Totals not selected
11 Adverse effects: nausea or vomiting	3	131	Odds Ratio (M-H, Fixed, 95% CI)	11.76 [2.59, 53.46]
12 Duration of hospitalization (days)			Other data	No numeric data